BNP Paribas Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $45.3M | Buy |
230,934
+5,640
| +3% | +$1.1M | 0.05% | 344 |
|
|
2025
Q4 | $39.1M | Sell |
225,294
-60,768
| -21% | -$11.1M | 0.04% | 358 |
|
|
2025
Q3 | $54.2M | Sell |
286,062
-7,877
| -3% | -$1.4M | 0.14% | 155 |
|
|
2025
Q2 | $52.8M | Buy |
293,939
+217,187
| +283% | +$37.7M | 0.13% | 162 |
|
|
2025
Q1 | $13M | Sell |
76,752
-124
| -0.2% | -$20.4K | 0.03% | 404 |
|
|
2024
Q4 | $11.6M | Sell |
76,876
-559
| -0.7% | -$86.9K | 0.03% | 431 |
|
|
2024
Q3 | $12M | Sell |
77,435
-1,575
| -2% | -$235K | 0.03% | 408 |
|
|
2024
Q2 | $10.8M | Sell |
79,010
-7,084
| -8% | -$970K | 0.03% | 411 |
|
|
2024
Q1 | $11.5M | Sell |
86,094
-24,721
| -22% | -$3.21M | 0.03% | 408 |
|
|
2023
Q4 | $15.3M | Sell |
110,815
-45,519
| -29% | -$5.98M | 0.04% | 345 |
|
|
2023
Q3 | $19.1M | Sell |
156,334
-40,760
| -21% | -$5.43M | 0.06% | 299 |
|
|
2023
Q2 | $27.7M | Buy |
197,094
+9,792
| +5% | +$1.35M | 0.09% | 236 |
|
|
2023
Q1 | $26.5M | Buy |
187,302
+29,554
| +19% | +$4.23M | 0.09% | 237 |
|
|
2022
Q4 | $24.7M | Sell |
157,748
-48,813
| -24% | -$7.01M | 0.09% | 261 |
|
|
2022
Q3 | $25.7M | Buy |
206,561
+25,137
| +14% | +$3.31M | 0.1% | 230 |
|
|
2022
Q2 | $24.1M | Sell |
181,424
-9,506
| -5% | -$1.3M | 0.09% | 251 |
|
|
2022
Q1 | $26.1M | Sell |
190,930
-4,373
| -2% | -$610K | 0.09% | 261 |
|
|
2021
Q4 | $33.8M | Buy |
195,303
+43,424
| +29% | +$6.61M | 0.11% | 216 |
|
|
2021
Q3 | $22.1M | Buy |
151,879
+13,219
| +10% | +$1.93M | 0.08% | 270 |
|
|
2021
Q2 | $18.3M | Buy |
138,660
+17,446
| +14% | +$2.28M | 0.07% | 336 |
|
|
2021
Q1 | $15.6M | Buy |
121,214
+24,651
| +26% | +$3.04M | 0.06% | 332 |
|
|
2020
Q4 | $11.5M | Buy |
96,563
+28,882
| +43% | +$3.52M | 0.05% | 356 |
|
|
2020
Q3 | $7.75M | Buy |
67,681
+15,752
| +30% | +$1.86M | 0.04% | 366 |
|
|
2020
Q2 | $5.92M | Sell |
51,929
-199,718
| -79% | -$21.2M | 0.04% | 395 |
|
|
2020
Q1 | $20.2M | Buy |
251,647
+15,340
| +6% | +$1.59M | 0.17% | 163 |
|
|
2019
Q4 | $25.2M | Buy |
236,307
+81,521
| +53% | +$8.5M | 0.17% | 169 |
|
|
2019
Q3 | $16.6M | Buy |
154,786
+35,614
| +30% | +$3.66M | 0.13% | 210 |
|
|
2019
Q2 | $12.1M | Buy |
119,172
+11,176
| +10% | +$1.07M | 0.1% | 263 |
|
|
2019
Q1 | $9.71M | Buy |
107,996
+31,329
| +41% | +$2.71M | 0.08% | 302 |
|
|
2018
Q4 | $6.29M | Buy |
76,667
+26,581
| +53% | +$2.49M | 0.06% | 392 |
|
|
2018
Q3 | $5.41M | Buy |
50,086
+9,030
| +22% | +$990K | 0.04% | 463 |
|
|
2018
Q2 | $4.51M | Sell |
41,056
-22,519
| -35% | -$2.35M | 0.04% | 502 |
|
|
2018
Q1 | $6.38M | Sell |
63,575
-3,459
| -5% | -$354K | 0.05% | 437 |
|
|
2017
Q4 | $6.6M | Sell |
67,034
-59,295
| -47% | -$5.62M | 0.06% | 426 |
|
|
2017
Q3 | $11.8M | Buy |
126,329
+16,376
| +15% | +$1.74M | 0.1% | 281 |
|
|
2017
Q2 | $12.2M | Buy |
109,953
+51,505
| +88% | +$5.45M | 0.11% | 256 |
|
|
2017
Q1 | $5.74M | Buy |
58,448
+42,004
| +255% | +$4M | 0.05% | 452 |
|
|
2016
Q4 | $1.51M | Sell |
16,444
-30,503
| -65% | -$2.63M | 0.01% | 704 |
|
|
2016
Q3 | $3.97M | Buy |
46,947
+1,163
| +3% | +$97.7K | 0.03% | 570 |
|
|
2016
Q2 | $3.73M | Buy |
45,784
+5,029
| +12% | +$383K | 0.03% | 562 |
|
|
2016
Q1 | $2.91M | Buy |
40,755
+2,992
| +8% | +$201K | 0.02% | 594 |
|
|
2015
Q4 | $2.69M | Sell |
37,763
-284,310
| -88% | -$19.1M | 0.02% | 606 |
|
|
2015
Q3 | $19.8M | Buy |
322,073
+29,456
| +10% | +$2.06M | 0.17% | 168 |
|
|
2015
Q2 | $21.2M | Sell |
292,617
-58,569
| -17% | -$4.32M | 0.17% | 167 |
|
|
2015
Q1 | $27M | Buy |
351,186
+62,492
| +22% | +$4.48M | 0.21% | 142 |
|
|
2014
Q4 | $19.4M | Sell |
288,694
-11,388
| -4% | -$719K | 0.16% | 176 |
|
|
2014
Q3 | $18.2M | Buy |
300,082
+26,285
| +10% | +$1.62M | 0.15% | 186 |
|
|
2014
Q2 | $16.1M | Buy |
273,797
+111,878
| +69% | +$6.55M | 0.12% | 213 |
|
|
2014
Q1 | $9.38M | Buy |
161,919
+110,879
| +217% | +$5.94M | 0.07% | 296 |
|
|
2013
Q4 | $2.73M | Buy |
51,040
+10,959
| +27% | +$650K | 0.02% | 562 |
|
|
2013
Q3 | $2.48M | Buy |
40,081
+18,188
| +83% | +$1.09M | 0.02% | 550 |
|
|
2013
Q2 | $1.33M | Buy |
+21,893
| New | +$1.3M | 0.01% | 633 |
|
Other funds holding DGX
VCM
VPM
EIG
BNP Paribas Asset Management's DGX Position: Q1 2026 in Review
BNP Paribas Asset Management increased its Quest Diagnostics (DGX) stake by 2.5% in Q1 2026, buying an estimated $1.1M and bringing the position to 230,934 shares worth $45.3M. The position accounts for 0.05% of the portfolio, ranked #344.
BNP Paribas Asset Management first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $54.2M in Q3 2025. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- BNP Paribas Asset Management held 230,934 shares of Quest Diagnostics worth $45.3M as of Q1 2026.
- BNP Paribas Asset Management bought 5,640 Quest Diagnostics shares in Q1 2026, an estimated $1.1M.
- Quest Diagnostics made up 0.05% of BNP Paribas Asset Management's portfolio in Q1 2026, its #344 holding.
- BNP Paribas Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Asset Management's Quest Diagnostics position peaked at $54.2M in Q3 2025.
- 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.